Updated survival analysis from the CLL11 study:Obinutuzumab versus rituximab in chemoimmunotherapy-treated patients with chronic lymphocytic leukemia

Autor:	Goede, V, Fischer, K., Bosch, F, Follows, G, Frederiksen, Henrik, Cuneo, A, Ludwig, H, Crompton, N, Maurer, J, Uguen, M, Fingerle-Rowson, G, Hallek, M
Jazyk:	angličtina
Rok vydání:	2015
Zdroj:	Goede, V, Fischer, K, Bosch, F, Follows, G, Frederiksen, H, Cuneo, A, Ludwig, H, Crompton, N, Maurer, J, Uguen, M, Fingerle-Rowson, G & Hallek, M 2015, ' Updated survival analysis from the CLL11 study : Obinutuzumab versus rituximab in chemoimmunotherapy-treated patients with chronic lymphocytic leukemia ', Blood, vol. 126, no. 23, 1733 . < https://ash.confex.com/ash/2015/webprogram/Paper80155.html >
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______3062::369e9554ac6c8e4904adf25892cd5738 http://www.bloodjournal.org/content/126/23/1733 Zobrazit plný text záznamu